<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7791836/table_4" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 4</label>
  <p>Pharmacological activities of patchouli in anti-inflammation</p>
 </caption>
 <thead>
  <tr>
   <th align="left" colspan="1" rowspan="1" id="0-0-.">Chemical name</th>
   <th align="left" colspan="1" rowspan="1" id="0-1-.">Animals/cells and Pathological model</th>
   <th align="left" colspan="1" rowspan="1" id="0-2-.">Type</th>
   <th align="left" colspan="1" rowspan="1" id="0-3-.">Efficient doses and administration route</th>
   <th align="left" colspan="1" rowspan="1" id="0-4-.">Results</th>
   <th align="left" colspan="1" rowspan="1" id="0-5-.">References</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" rowspan="2">β-PAE</td>
   <td align="left">LPS-stimulatedRAW264.7 macrophages</td>
   <td align="left">In vitro</td>
   <td align="left">10, 20, 40 μmol/L</td>
   <td align="left">TNF-α↓, IL-6↓, IL-1β↓, IL-10↑, iNOS↓, COX-2↓, NO↓, PGE2↓</td>
   <td align="left">[ 
    <a ref-type="bibr" rid="CR99">99</a>] 
   </td>
  </tr>
  <tr>
   <td align="left">Kun Ming (KM) mice; Xylene-induced ear edema, Acetic acid-induced vascular permeability, Carrageenan-induced paw edema</td>
   <td align="left">In vivo</td>
   <td align="left">10, 20, 40 mg/kgoral administration</td>
   <td align="left">MDA↓, MPO↓, TNF-α↓, IL-1β↓, PGE2↓, IL-6↓, NO↓, iNOS↓, COX-2↓, p65 (nuclear)↓</td>
   <td align="left">[ 
    <a ref-type="bibr" rid="CR100">100</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="2">PAO</td>
   <td align="left">KM mice; Xylene-induced ear edema, Acetic acid-induced vascular permeability, Carrageenan-induced paw edema</td>
   <td align="left">In vivo</td>
   <td align="left">10, 20, 40 mg/kg oral administration</td>
   <td align="left">TNF-α↓, IL-1β↓, IL-6↓, PGE2↓, NO↓, IL-4↑, IL-10↑, COX-2↓, iNOS↓, p-IKKβ and IκBα↓</td>
   <td align="left">[ 
    <a ref-type="bibr" rid="CR102">102</a>] 
   </td>
  </tr>
  <tr>
   <td align="left">LPS-stimulated RAW264.7 macrophages</td>
   <td align="left">In vitro</td>
   <td align="left">10, 20, 40 μmol/L</td>
   <td align="left">TNF-α↓, IL-12↓, IL-1β↓, MCP-1↓, PGE2↓, NO↓, iNOS↓, COX-2↓</td>
   <td align="left">[ 
    <a ref-type="bibr" rid="CR103">103</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="3">PO</td>
   <td align="left">Swiss mice; Zymosan-induced peritonitis</td>
   <td align="left">In vivo</td>
   <td align="left">100, 200, 300 mg/kg oral administration</td>
   <td align="left">Leukocyte recruitment↓, NO↓, leukocyte number↓</td>
   <td align="left" rowspan="3">[ 
    <a ref-type="bibr" rid="CR104">104</a>] 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="2">fMLP-induced neutrophils</td>
   <td align="left" rowspan="2">In vitro</td>
   <td align="left">1, 3, 10, 30, 60, 90 mg/ml</td>
   <td align="left">Neutrophil migration↓</td>
  </tr>
  <tr>
   <td align="left">3, 10 mg/ml</td>
   <td align="left">Phagocytic activity of neutrophils↑</td>
  </tr>
 </tbody>
 <tfoot>
  <p>Note: Arrow up denotes activation; arrow down denotes suppression</p>
 </tfoot>
</table>
